Cargando…

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?

Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Golubeva, Julia A., Sheptulina, Anna F., Elkina, Anastasia Yu., Liusina, Ekaterina O., Kiselev, Anton R., Drapkina, Oxana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525922/
https://www.ncbi.nlm.nih.gov/pubmed/37760906
http://dx.doi.org/10.3390/biomedicines11092465
_version_ 1785110899299713024
author Golubeva, Julia A.
Sheptulina, Anna F.
Elkina, Anastasia Yu.
Liusina, Ekaterina O.
Kiselev, Anton R.
Drapkina, Oxana M.
author_facet Golubeva, Julia A.
Sheptulina, Anna F.
Elkina, Anastasia Yu.
Liusina, Ekaterina O.
Kiselev, Anton R.
Drapkina, Oxana M.
author_sort Golubeva, Julia A.
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.
format Online
Article
Text
id pubmed-10525922
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105259222023-09-28 Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension? Golubeva, Julia A. Sheptulina, Anna F. Elkina, Anastasia Yu. Liusina, Ekaterina O. Kiselev, Anton R. Drapkina, Oxana M. Biomedicines Review Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms. MDPI 2023-09-05 /pmc/articles/PMC10525922/ /pubmed/37760906 http://dx.doi.org/10.3390/biomedicines11092465 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Golubeva, Julia A.
Sheptulina, Anna F.
Elkina, Anastasia Yu.
Liusina, Ekaterina O.
Kiselev, Anton R.
Drapkina, Oxana M.
Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title_full Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title_fullStr Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title_full_unstemmed Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title_short Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
title_sort which comes first, nonalcoholic fatty liver disease or arterial hypertension?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525922/
https://www.ncbi.nlm.nih.gov/pubmed/37760906
http://dx.doi.org/10.3390/biomedicines11092465
work_keys_str_mv AT golubevajuliaa whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension
AT sheptulinaannaf whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension
AT elkinaanastasiayu whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension
AT liusinaekaterinao whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension
AT kiselevantonr whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension
AT drapkinaoxanam whichcomesfirstnonalcoholicfattyliverdiseaseorarterialhypertension